Jacob Grow
Plastic Surgery · Cleveland, OHNPI 1487071650
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,513 of the $7,845 with a category attached, or 70.3%. It is spread thinly across 17 manufacturers, the largest accounting for just 20.5%. 2025 is the largest year on record at $3,782, 4.6 times the $822 reported in 2019.
Across 90 payments — averaging $87.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Musculoskeletal Transplant Foundation Inc.$2K
- Motiva USA, LLC$1K
- Tepha Inc$898
- Sientra, Inc.$739
- AbbVie$506
- plus $1K from 11 others
What the payments were for
- Travel & lodging$6939%
- Food & beverage$5,51370%
- Gifts$871%
- Other$1,55320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 5 | $1,606 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $1,590 |
| Motiva USA, LLC | 14 | $1,262 |
| Tepha Inc | 9 | $898 |
| Sientra, Inc. | 11 | $739 |
| AbbVie(2 entities) | 10 | $506 |
| Mentor Worldwide LLC | 17 | $445 |
| Bard Peripheral Vascular, Inc. | 4 | $209 |
| Davol Inc. | 2 | $198 |
| Axogen | 2 | $110 |
| Smith+Nephew | 1 | $92 |
| Vertex | 2 | $48 |
| Stryker | 1 | $48 |
| Merz North America, Inc. | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Kerecis Limited | 1 | $20 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,845 in reported general payments places this provider in the 80th percentile of 191 plastic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 52 | $395 |
| Oxycodone Hcl | 43 | $151 |
| Doxycycline Hyclate | 21 | $135 |
| Ondansetron Hcl | 21 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Cleveland
- Christopher SurekCleveland$1M
- Risal DjohanCleveland$330K
- Brian GastmanCleveland$88K
- Anthony TufaroCleveland$56K
- Maria SiemionowCleveland$28K
- Sarah BishopCleveland$24K
- Rachel AliottaCleveland$14K
- Meenakshi RajanCleveland$14K
- Donald HarveyCleveland$9K
- Raymond IsakovCleveland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.